General form of registration statement for all companies including face-amount certificate companies

Nature of Business and Summary of Significant Accounting Policies (Tables)

v3.22.4
Nature of Business and Summary of Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]    
Summary of Antidilutive Shares Excluded from Calculation of Dilutive Loss Per Share

The following table summarizes the Company’s potentially dilutive securities, in common share equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:

 

 

 

Nine Months Ended

September 30,

 

 

 

2022

 

 

2021

 

Shares issuable upon exercise of stock options

 

 

6,511,910

 

 

 

5,666,267

 

Shares issuable upon exercise of warrants

 

 

796,985

 

 

 

1,594,733

 

Unvested restricted stock awards

 

 

 

 

 

58,333

 

The following table summarizes the Company’s potentially dilutive securities, in common share equivalents, which have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive:

 

 

 

Year ending December 31,

 

 

 

2021

 

 

2020

 

Shares issuable upon exercise of stock options

 

 

5,797,185

 

 

 

3,664,966

 

Shares issuable upon exercise of warrants

 

 

1,311,117

 

 

 

908,244

 

Unvested restricted stock awards

 

 

58,333

 

 

 

147,778